Published in Am J Public Health on July 01, 2001
Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr (2009) 4.20
The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS (2009) 3.78
HIV/AIDS stigma: an impediment to public health. Am J Public Health (2002) 3.08
Test-retest reliability of self-reported HIV/STD-related measures among African-American adolescents in four U.S. cities. J Adolesc Health (2008) 2.20
High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav (2010) 2.18
Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88
HIV behavioral surveillance in the U.S.: a conceptual framework. Public Health Rep (2007) 1.87
Don't ask, don't tell: patterns of HIV disclosure among HIV positive men who have sex with men with recent STI practising high risk behaviour in Los Angeles and Seattle. Sex Transm Infect (2004) 1.81
Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa. J Acquir Immune Defic Syndr (2008) 1.66
Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysis. AIDS Behav (2006) 1.63
Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition. HIV Med (2013) 1.57
The status of national HIV case surveillance, United States 2006. Public Health Rep (2007) 1.53
Preventing HIV transmission with antiretrovirals. Bull World Health Organ (2009) 1.50
Infections prevented by increasing HIV serostatus awareness in the United States, 2001 to 2004. J Acquir Immune Defic Syndr (2008) 1.49
Secondary prevention of HIV infection: the current state of prevention for positives. Curr Opin HIV AIDS (2009) 1.46
Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island. AIDS Read (2008) 1.42
Association between testing for human immunodeficiency virus and changes in risk behaviors among injecting drug users in southern China. Sex Transm Dis (2009) 1.41
A behavioral intervention reduces HIV transmission risk by promoting sustained serosorting practices among HIV-infected men who have sex with men. J Acquir Immune Defic Syndr (2008) 1.41
An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men. J Urban Health (2004) 1.38
Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS (2010) 1.34
HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada. Sex Transm Infect (2004) 1.33
Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison. AIDS Res Ther (2008) 1.30
Secondary prevention of HIV in the United States: past, current, and future perspectives. J Acquir Immune Defic Syndr (2010) 1.29
HIV/AIDS-related stigmatizing and discriminatory attitudes and recent HIV testing among men who have sex with men in Beijing. AIDS Behav (2012) 1.29
Discussion of HIV status by serostatus and partnership sexual risk among internet-using MSM in the United States. J Acquir Immune Defic Syndr (2012) 1.26
Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: the BESURE study. J Acquir Immune Defic Syndr (2011) 1.25
Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health (2004) 1.20
The magnitude of key HIV prevention challenges in the United States: implications for a new national HIV prevention plan. Am J Public Health (2007) 1.20
Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health (2006) 1.20
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC Infect Dis (2011) 1.18
Alternative HIV testing methods among populations at high risk for HIV infection. Public Health Rep (2003) 1.17
Can you hear me now? Limited use of technology among an urban HIV-infected cohort. AIDS Care (2009) 1.17
A comparison of audio computer-assisted self-interviews to face-to-face interviews of sexual behavior among perinatally HIV-exposed youth. Arch Sex Behav (2011) 1.17
Risk factors for the spread of HIV and other sexually transmitted infections among men who have sex with men infected with HIV in Lima, Peru. Sex Transm Infect (2008) 1.16
Behavioral and serologic survey of men who have sex with men in Beijing, China: implication for HIV intervention. AIDS Patient Care STDS (2012) 1.16
CDC recommendations for opt-out testing and reactions to unanticipated HIV diagnoses. AIDS Patient Care STDS (2008) 1.14
Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities. Drug Alcohol Rev (2008) 1.14
Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends. J Urban Health (2008) 1.13
Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine (2013) 1.12
HIV-untested men who have sex with men in South Africa: the perception of not being at risk and fear of being tested. AIDS Behav (2013) 1.04
Unprotected anal intercourse among HIV-positive men who have a steady male sex partner with negative or unknown HIV serostatus. Am J Public Health (2005) 1.03
Recruiting drug-using men who have sex with men into behavioral interventions: a two-stage approach. J Urban Health (2005) 1.03
Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse (2006) 1.02
Improving HIV rapid testing rates among STD clinic patients: a randomized controlled trial. Health Psychol (2008) 1.00
Ensuring timely access to care for people with HIV infection: a public health imperative. Am J Public Health (2002) 0.99
The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic population. AIDS Patient Care STDS (2010) 0.97
Advancing HIV prevention demonstration projects: new strategies for a changing epidemic. Public Health Rep (2009) 0.95
Risk factors for HIV disease progression in a rural southwest American Indian population. Public Health Rep (2010) 0.94
Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. J Subst Abuse Treat (2007) 0.94
Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement? Challenge (Atlanta Ga) (2007) 0.93
HIV prevention service utilization in the Los Angeles House and Ball communities: past experiences and recommendations for the future. AIDS Educ Prev (2012) 0.93
An HIV agenda for the new administration. Am J Public Health (2001) 0.92
Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations. AIDS (2008) 0.92
HIV-positive men sexually active with women: sexual behaviors and sexual risks. J Urban Health (2006) 0.92
A novel emergency department based prevention intervention program for people living with HIV: evaluation of early experiences. BMC Health Serv Res (2007) 0.92
Perceived risk as a moderator of the effectiveness of framed HIV-test promotion messages among women: a randomized controlled trial. Health Psychol (2011) 0.91
HIV prevention in high-risk women in South Africa: condom use and the need for change. PLoS One (2012) 0.91
High rates of HIV testing despite low perceived HIV risk among African-American sexually transmitted disease patients. J Natl Med Assoc (2006) 0.91
Assessing the impact of federal HIV prevention spending on HIV testing and awareness. Am J Public Health (2006) 0.88
Social support and delays seeking care after HIV diagnosis, North Carolina, 2000-2006. AIDS Care (2009) 0.87
Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China--a prospective study. Harm Reduct J (2013) 0.86
HIV partner notification: predictors of discussion and agreements from provider reports. AIDS Behav (2009) 0.86
Missed connections: HIV-infected people never in care. Public Health Rep (2013) 0.85
Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study. PLoS One (2014) 0.85
Geospatial methods for identification of core groups for HIV/AIDS. Subst Use Misuse (2008) 0.84
The effect of a local change team intervention on staff attitudes towards HIV service delivery in correctional settings: a randomized trial. AIDS Educ Prev (2014) 0.82
HIV seropositive drug users' attitudes towards partner notification (PCRS): results from the SHIELD study in Baltimore, Maryland. Patient Educ Couns (2007) 0.82
Expanding the horizons: new approaches to providing HIV testing services in the United States. Public Health Rep (2009) 0.81
Sero-skeptics: discussions between test counselors and their clients about sexual partner HIV status disclosure. AIDS Care (2009) 0.81
Symptoms of psychological distress: a comparison of rural and urban individuals enrolled in HIV-related mental health care. AIDS Patient Care STDS (2009) 0.80
AIDS Exceptionalism: On the Social Psychology of HIV Prevention Research. Soc Issues Policy Rev (2009) 0.80
HIV transmission risk behaviors among people living with HIV/AIDS: the need to integrate HIV prevention interventions and public health strategies into HIV care. J Public Health Manag Pract (2015) 0.80
Perceptions of alcohol risk among individuals living with HIV. AIDS Care (2011) 0.79
The future of HIV prevention: control of sexually transmitted infections and circumcision interventions. Infect Dis Clin North Am (2007) 0.79
HIV testing policy and serious mental illness. Am J Public Health (2002) 0.78
Assessing base rates of sexual behavior using the unmatched count technique. Health Psychol Behav Med (2014) 0.78
Association of Internalized and Social Network Level HIV Stigma With High-Risk Condomless Sex Among HIV-Positive African American Men. Arch Sex Behav (2015) 0.77
HIV testing practices among women living in public housing in Puerto Rico. J Womens Health (Larchmt) (2008) 0.77
Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium. J Urban Health (2006) 0.77
African American women and HIV/AIDS: a national call for targeted health communication strategies to address a disparity. AIDS Read (2009) 0.77
Amplified transmission of HIV-1: missing link in the HIV pandemic. Trans Am Clin Climatol Assoc (2006) 0.77
An analysis of the serostatus approach to fighting the HIV epidemic. Am J Public Health (2002) 0.77
HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. AIDS Care (2015) 0.77
Variation in local health department primary care services as a function of health center availability. J Public Health Manag Pract (2014) 0.76
Engagement in HIV Prevention Advocacy Associated with Increased Consistent Condom Use Among HIV Clients in Uganda. AIDS Behav (2015) 0.75
The serostatus approach to HIV prevention and care: cautions and caveats. Am J Public Health (2002) 0.75
Point-of-Care HIV Testing and Linkage in an Urban Cohort in the Southern US. AIDS Res Treat (2013) 0.75
The Impact of Visual Aids and Enhanced Training on the Delivery of Positive Health, Dignity, and Prevention Messages to Adult Patients Living with HIV in Rural North Central Mozambique. PLoS One (2015) 0.75
Compliance with a New York State 2010 HIV Testing Law: Is There Racial/Ethnic Bias in HIV Testing? Experience of Monroe County, New York, 2012. Ethn Dis (2016) 0.75
Completing the public health HIV/AIDS alphabet. PLoS Med (2005) 0.75
Knowledge of Human Immunodeficiency Virus Status and Seropositivity After a Recently Negative Test in Malawi. Open Forum Infect Dis (2016) 0.75
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1994) 25.02
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA (1998) 9.32
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet (1999) 8.98
Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA (1991) 7.35
The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med (1998) 6.26
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Transmission dynamics of HIV infection. Nature (1987) 4.84
Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr (1994) 4.81
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12
HIV-1 drug resistance in newly infected individuals. JAMA (1999) 3.49
Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med (1998) 3.45
Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS (1997) 3.42
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med (1998) 3.14
Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA (1999) 2.82
Drug abuse treatment as AIDS prevention. Public Health Rep (1998) 2.80
Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS (1997) 2.51
On-site, rapid HIV testing with same-day results and counseling. AIDS (1997) 2.44
Trends in HIV incidence among young adults in the United States. JAMA (1998) 2.28
Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS (1999) 2.15
Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 2.00
Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses (1998) 1.99
Sexual behavior of individuals infected with the human immunodeficiency virus. The need for intervention. Arch Intern Med (1994) 1.96
Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study Group. Ann Intern Med (1999) 1.94
Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS (1997) 1.93
Promoting early HIV diagnosis and entry into care. AIDS (1999) 1.68
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol (1997) 1.62
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis (1996) 1.46
Living with HIV. Experiences and perspectives of HIV-infected sexually transmitted disease clinic patients after posttest counseling. Sex Transm Dis (1998) 1.45
Prevalence of sexual and drug-related HIV risk behaviors in the U.S. adult population: results of the 1996 National Household Survey on Drug Abuse. J Acquir Immune Defic Syndr (1999) 1.45
Mucosal transmission of simian immunodeficiency virus. Curr Top Microbiol Immunol (1994) 1.43
Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis (1999) 1.38
Heterosexual HIV-1 transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.36
Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.30
Behavioral and biologic evidence of persistent high-risk behavior in an HIV primary care population. AIDS (2000) 1.18
Effect of knowledge of human immunodeficiency virus infection status on sexual activity among homosexual men. J Acquir Immune Defic Syndr (1990) 1.15
A standardized psychiatric interview for use in community surveys. Br J Prev Soc Med (1970) 9.38
AIDS as a zoonosis: scientific and public health implications. Science (2000) 8.28
HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health (2001) 6.29
Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet (1993) 3.28
Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Public Health (2001) 3.27
Mental health care in the community: an evaluative study. Psychol Med (1975) 3.13
The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. J Fam Pract (1992) 2.97
The development of a computerized assessment for minor psychiatric disorder. Psychol Med (1988) 2.95
A study of the classification of mental ill-health in general practice. Psychol Med (1985) 2.88
Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA (1993) 2.87
Expansion of surveillance case definition for AIDS in resource-poor countries. Lancet (1993) 2.80
Birth of a relativistic outflow in the unusual γ-ray transient Swift J164449.3+573451. Nature (2011) 2.47
Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet (1995) 2.42
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers. Am J Public Health (2000) 2.31
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia (2013) 2.13
Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet (1997) 2.12
Tuberculosis control in South Africa--time for a new paradigm? S Afr Med J (1996) 2.08
Clinical research, prophylaxis, therapy, and care for HIV disease in Africa. Am J Public Health (1993) 2.07
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA (1996) 2.07
Provider-initiated HIV testing and counselling for TB patients and suspects in Nairobi, Kenya. Int J Tuberc Lung Dis (2008) 2.05
Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract (1991) 2.05
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.02
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS (1996) 1.95
Disease in children infected with HIV in Abidjan, Côte d'Ivoire. BMJ (1996) 1.92
Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis (1992) 1.92
Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int (2000) 1.87
An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med (1973) 1.85
Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA (1994) 1.84
The relationship between eye movements and spatial attention. Q J Exp Psychol A (1986) 1.82
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis (2011) 1.76
Contribution of tuberculosis to slim disease in Africa. BMJ (1994) 1.73
Promoting early HIV diagnosis and entry into care. AIDS (1999) 1.68
Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med (2011) 1.68
CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Rep (1990) 1.66
Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet (1968) 1.66
HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS (2000) 1.65
An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Rep (1995) 1.62
The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep (1987) 1.62
The use of theory based semistructured elicitation questionnaires: formative research for CDC's Prevention Marketing Initiative. Public Health Rep (1996) 1.61
Acquired immunodeficiency syndrome among adolescents. Case surveillance profiles in New York City and the rest of the United States. Am J Dis Child (1989) 1.60
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest (1999) 1.60
The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med (1983) 1.59
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med (1997) 1.58
Circumcision: a decision analysis of its medical value. Fam Med (1992) 1.55
Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS (1997) 1.55
A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychol Med (1978) 1.54
Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect (2002) 1.53
Associations between internet sex seeking and STI associated risk behaviours among men who have sex with men. Sex Transm Infect (2003) 1.53
Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. BMJ (1992) 1.51
The growing challenge of HIV/AIDS in developing countries. Br Med Bull (1998) 1.48
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes (2001) 1.47
Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection. Sex Transm Dis (1994) 1.45
What price psychotherapy? Br Med J (Clin Res Ed) (1984) 1.45
Spectrum of disease in Africans with AIDS in London. AIDS (1996) 1.43
Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. Arch Pathol Lab Med (1992) 1.42
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med (1996) 1.40
The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data. AIDS (1998) 1.39
The child who dislikes going to school. Br J Educ Psychol (1967) 1.39
Is post-exposure prophylaxis affordable? AIDS (2000) 1.39
Risk factors for HIV infection among abandoned Romanian children. AIDS (1993) 1.39
Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS (1998) 1.37
American adults' knowledge of HIV testing availability. Am J Public Health (1993) 1.37
HIV-1 infection in young men in northern Thailand. AIDS (1993) 1.35
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med (2000) 1.34
Estimating the value of preventing a human immunodeficiency virus infection. Am J Prev Med (1994) 1.34
Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS (1999) 1.32
Early evaluation of psychotropic drugs in man. A trial that failed. Lancet (1967) 1.32
The effect of group education on improving attitudes about AIDS risk reduction. N Y State J Med (1987) 1.32
Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int J Tuberc Lung Dis (2000) 1.32
Informational privacy and the public's health: the Model State Public Health Privacy Act. Am J Public Health (2001) 1.32
A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia (2000) 1.31
Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Rep (1996) 1.30
Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg (1996) 1.30
An experiment in community mental health care. Lancet (1974) 1.29
Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis (2008) 1.28
Model-based evaluation of HIV prevention interventions. Eval Rev (1998) 1.26
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes (2001) 1.25
Epidemiology and clinical psychiatry. Br J Psychiatry (1978) 1.25
Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Côte d'Ivoire. Int J Tuberc Lung Dis (1998) 1.25
The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol (1995) 1.25
Continuation therapy with tricyclic antidepressants in depressive illness. Lancet (1972) 1.25
Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med (1984) 1.24
HIV-1 and HIV-2 infections in men attending sexually transmitted disease clinics in Abidjan, Côte d'Ivoire. AIDS (1992) 1.23
Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. AIDS (2001) 1.22
Decision-making in HIV prevention community planning: an integrative review. J Community Health (2000) 1.22
Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med (1999) 1.22
Sacrococcygeal teratomas: a review of 68 cases. Cancer (1981) 1.21
A comparison of amebic and pyogenic abscess of the liver. Medicine (Baltimore) (1987) 1.21
Social work and the primary care of mental disorder. Psychol Med (1979) 1.20
Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med (1994) 1.20
Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabet Med (2009) 1.20
The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med (1988) 1.19